openPR Logo
Press release

Investigation announced for Investors in NASDAQ:STIM shares over possible Wrongdoing at Neuronetics, Inc.

10-28-2019 05:11 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation on behalf of investors in Neuronetics, Inc. (NASDAQ: STIM) shares over potential wrongdoing at Neuronetics, Inc.

An investigation on behalf of investors in Neuronetics, Inc. (NASDAQ: STIM) shares over potential wrongdoing at Neuronetics, Inc.

An investigation on behalf of investors in shares of Neuronetics, Inc. (NASDAQ: STIM) was announced over potential breaches of fiduciary duties by certain officers and directors at Neuronetics, Inc.

Investors who purchased shares of Neuronetics, Inc. (NASDAQ: STIM) and currently hold any of those NASDAQ: STIM shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain Neuronetics, Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders.

Malvern, PA based Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with psychiatric disorders in the United States, Japan, and internationally. Neuronetics, Inc went public in June 2018 and sold 5.5 million shares at $17.00 per share in its initial public offering (“IPO”).

Since then, shares of Neuronetics, Inc. (NASDAQ: STIM) declined to as low as $10.91 per share on July 23, 2019.

Those who purchased shares of Neuronetics, Inc. (NASDAQ: STIM) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors in NASDAQ:STIM shares over possible Wrongdoing at Neuronetics, Inc. here

News-ID: 1857568 • Views:

More Releases from Shareholders Foundation

Lawsuit for Investors in Sonder Holdings Inc. (NASDAQ: SOND) filed in effort to recover losses
Lawsuit for Investors in Sonder Holdings Inc. (NASDAQ: SOND) filed in effort to …
An investor, who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND), filed a lawsuit over alleged violations of Federal Securities Laws by Sonder Holdings Inc in connection with certain allegedly false and misleading statements. Investors who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: SOND investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com
Lawsuit filed for Investors in Ocugen, Inc. (NASDAQ: OCGN) in effort to recover losses
Lawsuit filed for Investors in Ocugen, Inc. (NASDAQ: OCGN) in effort to recover …
An investor, who purchased shares of Ocugen, Inc. (NASDAQ: OCGN), filed a lawsuit i over alleged violations of Federal Securities Laws by Ocugen, Inc.. Investors who purchased shares of Ocugen, Inc. (NASDAQ: OCGN) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: OCGN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. Malvern, PA based Ocugen, Inc., a
Investors who lost money with shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) should contact the Shareholders Foundation in connection with Lawsuit
Investors who lost money with shares of Evolv Technologies Holdings, Inc. (NASDA …
An investor, who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV), filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged violations of Federal Securities Laws by Evolv Technologies Holdings, Inc. f/k/a NewHold Investment Corp. Investors who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) have certain options and for certain investors are short and strict deadlines running. Deadline: May 24, 2024. NASDAQ: EVLV
Investigation announced for Investors who purchased shares of Comtech Telecommunications Corp. (NASDAQ: CMTL) over possible Violations of Securities Laws
Investigation announced for Investors who purchased shares of Comtech Telecommun …
Comtech Telecommunications Corp is under investigation over potential securities laws violations in connection with certain financial statements. Investors who purchased shares of Comtech Telecommunications Corp. (NASDAQ: CMTL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Comtech Telecommunications Corp. regarding its business, its prospects and its operations were materially false

All 5 Releases


More Releases for Neuronetics

Neurostimulation Devices Market Analysis & Technological Innovation by Leading K …
MarketStudyReport.com Adds New Neurostimulation Devices Market 2017 – 2024 research report providing information and data By Product, By Application, Industry Analysis, Regional Outlook, Application Potential, Trends, Competitive Market Share & Forecast spreading across 130 Pages with table and figures in it. Historical data from 2013 is provided Neurostimulation market along with estimates and forecasts to 2024 based on segmentation of Neurostimulation industry by Product, by Application, companies and regions. Previous years’
Boston Scientific Corporation, Medtronic Neurostimulation Devices Market 2024 To …
According to Market Study Report, Neurostimulation Devices Market provides a comprehensive analysis of the Neurostimulation Devices market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities of global industry. This report also provides market landscape and market share information in the Neurostimulation Devices market. Historical data from 2013 is provided Neurostimulation market along with estimates and forecasts to 2024 based on segmentation of Neurostimulation
Neurostimulation Devices Market 2024 Global Analysis By Key Players - Boston Sci …
MarketStudyReport.com Adds New Neurostimulation Devices Market 2017 – 2024 research report providing information and data By Product, By Application, Industry Analysis, Regional Outlook, Application Potential, Trends, Competitive Market Share & Forecast spreading across 130 Pages with table and figures in it. Historical data from 2013 is provided Neurostimulation market along with estimates and forecasts to 2024 based on segmentation of Neurostimulation industry by Product, by Application, companies and regions. Previous years’
Global Deep Brain Stimulation Devices Market 2017 Industry Drivers : Neuropace, …
Qyresearchreports include new market research report "Global Deep Brain Stimulation Devices Sales Market Report 2017" to its huge collection of research reports. In this report, the global Deep Brain Stimulation Devices market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions,
Global Diaphragm Pacing Device Market 2017 Neurosigma, Neuropace, Neuronetics, C …
Diaphragm Pacing Device Market Research Report 2017 A market study ” Global Diaphragm Pacing Device Market ” examines the performance of the Diaphragm Pacing Device market Size 2017. It encloses an in-depth Research of the Diaphragm Pacing Device market state and the competitive landscape globally. This report analyzes the potential of Diaphragm Pacing Device market in the present and the future prospects from various angles in detail. The Global Diaphragm Pacing Device
Global Neuro Stimulation Devices Market 2017 : Neuronetics, NDI Medical, LLC, Ne …
Global Neuro Stimulation Devices Market 2016 - 2017 A market study based on the " Neuro Stimulation Devices Market " across the globe, recently added to the repository of Market Research, is titled ‘Global Neuro Stimulation Devices Market 2017’. The research report analyses the historical as well as present performance of the worldwide Neuro Stimulation Devices industry, and makes predictions on the future status of Neuro Stimulation Devices market on the